chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported nausea, vomiting, joint pain, numbness and tingling in both arms, a rash over neck, arms and trunk, and a feeling of shortness of breath.
I had periacardytis,  and muscle aches. Then my legs started swelling and I have had chronic pain in all my joints. I had blood work the previous year and everything was great. I lived a very healthy year. Now I have a fatty liver , I am pre diabetic and I have chronic pain, heart palpitations, swollen legs.
This is a spontaneous report from a contactable consumer or other non-HCP. A 21-year-old male patient received BNT162B2 (Comirnaty, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported.  The patient experienced rashes and welts on an unspecified date; with outcome of unknown. No follow-up attempts needed. Information about lot/batch number cannot be obtained.
Shortness of Breath - self corrected around May 9 Tachycardia - self corrected around May 18 Panic Attacks - still occurring, but steadily lessening in frequency and intensity
Fainted, increased pulse. Unable to walk, fatigue, H/A. EMT called pt. went to ER.
Pt recvd 2 doses of Engerix-B 7AUG92 w/in 30 minutes of 2nd dose had heart palpitations, extremely hot flashes, perspiring, lightheadedness; 8AUG92 had h/a, stiffness;
pt recv vax;c/o severe arm pain,which MD determined was an axillary nerve problem resulting from myelin sheath degeneration,possibly due to multi IM inject;
pt c/o chills, shakes, h/a;BP 130/80;10:40 BP 130/80, t93.6, P104;external warming was started @ this point;pt c/o diff breathing @ 11:00 02 was begun, IV (LP) started;BP dropped to 90/60,P100 & T99;c/o nausea & started to vomit;to ER
Chills; nausea,; pain in the injection site/ it is real sore; headache; couldn't get comfortable; feels unstable; feels dizzy; did not get enough sleep; achy; violently shaking; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DISCOMFORT (couldn't get comfortable), FEELING ABNORMAL (feels unstable), DIZZINESS (feels dizzy), INSOMNIA (did not get enough sleep) and PAIN (achy) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient had COVID-19 back in November.). Concurrent medical conditions included Stomach upset (patient has stomach problem), Diverticulitis, Heart disorder and Allergy. Concomitant products included TRAMADOL and CYANOCOBALAMIN (B12-VITAMIIN) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DISCOMFORT (couldn't get comfortable), FEELING ABNORMAL (feels unstable), DIZZINESS (feels dizzy), INSOMNIA (did not get enough sleep), PAIN (achy), TREMOR (violently shaking), HEADACHE (headache) and VACCINATION SITE PAIN (pain in the injection site/ it is real sore). On an unknown date, the patient experienced CHILLS (Chills) and NAUSEA (nausea,). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, DISCOMFORT (couldn't get comfortable), FEELING ABNORMAL (feels unstable), DIZZINESS (feels dizzy), INSOMNIA (did not get enough sleep), PAIN (achy), TREMOR (violently shaking), CHILLS (Chills), HEADACHE (headache), NAUSEA (nausea,) and VACCINATION SITE PAIN (pain in the injection site/ it is real sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt noticed redness, swelling, warm to touch this morning, at about 8:00AM (4/25/13). Came into clinic, induration measured at 9x9 cm on left deltoid area. Mother instructed by PA to apply cold compresses and administer MOTRIN until swelling and redness subsides. Mother ok with instructions. Advised to come into clinic if symptoms worsen.
awoke from hearing music while napping; having "a buzzing in his ears"; left arm soreness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 03Mar2021 (Lot number: EN6201) at the age of 70 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "blood pressure" (unspecified if ongoing), notes: He only has high blood pressure and takes a medicine for that. The patient took concomitant medications.  The following information was reported: TINNITUS (non-serious) with onset 03Mar2021, outcome "unknown", described as "having "a buzzing in his ears""; PAIN IN EXTREMITY (non-serious) with onset 03Mar2021, outcome "unknown", described as "left arm soreness"; SLEEP DISORDER (non-serious) with onset 06Mar2021, outcome "recovered" (06Mar2021), described as "awoke from hearing music while napping". The event "having "a buzzing in his ears"" was evaluated at the physician office visit.  Additional information: The patient reported that he received his first COVID vaccine on 03Mar2021 and one day later began having a buzzing in his ears. He reported that it was a persistent buzzing and that it was worse when he is in a silent area and better when there are other noised around him. The patient reported that he received his second vaccine dose on 24Mar20221 and after that the buzzing increased a little bit, reduced but still irritating. The patient saw his general practitioner and was told he has no hearing deficit.  The patient had a mild feeling, later described as a soreness in the left arm that started 6 hours after the first dose and went away after 24 hours. It was just noticeable; it was not a problem. On 6Mar2021 while napping, he was awakened by what he thought was his device playing music. It sounded like elevator music. It was peculiar. It was a distinct sound of music that woke him up, but he saw that the device was off. This was alarming to him. The patient added that the physician scoped and looked into his ears and told him that he did not have a hearing disability. The physician told him to follow up with an ear, nose, and throat specialist. The patient stated it probably wouldn't make any difference and he did not need to take a hearing test. The patient added he is very healthy and has not had the flu for 12 years.  No follow-up attempts are possible. No further information is expected.
swelling & red hives to lt upper arm;also c/o pain;no other sx;
Patient developed uticaria on anterior neck, upper chest, back, and upper arms. Uticaria developed one day after vaccine administration (02/05/2018) and persisted through 02/10/2018 when he was sent to the emergency room. No fever, difficulty breathing, swollen airway noticed or complained of.
Approximately 1 week after my second dose of the Pfizer-BioNTech COVID-19 vaccine on May 1st I started experiencing right calf pain. On May 11th, I was diagnosed with a DVT in that same calf.; Approximately 1 week after my second dose of the Pfizer-BioNTech COVID-19 vaccine on May 1st I started experiencing right calf pain. On May 11th, I was diagnosed with a DVT in that same calf. I was ad; This is a spontaneous report from a contactable consumer (patient). A 23-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Lot Number: EW0172) via an unspecified route of administration on 24Apr2021 (at the age of 23-year-old), as dose 2, single in right arm for COVID-19 immunization. The patient's medical history included migraine, anxiety, and panic attack from an unknown date and unknown if ongoing. Concomitant medication included alprazolam (XANAX), paracetamol (TYLENOL), ethinylestradiol, norethisterone acetate (JUNEL) and Keto Karma Fat Burn Red; all taken for unspecified indications, start and stop dates were not reported. The patient previously took Aimovig and experienced drug allergy. The patient's historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Lot Number: ER8734) via an unspecified route of administration on 02Apr2021 (at the age of 23-year-old), as single dose in right arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 01May2021 at 17:00, 7 days and 17 hours (approximately 1 week) after the administration of the second dose of vaccine, the patient experienced right calf pain. On May 11th, 17 days after the administration of the second dose of vaccine, the patient was diagnosed with a deep vein thrombosis (DVT) in that same calf. Adverse events resulted in Emergency Room visit and Physician Office Visit. Treatment medication included blood thinners. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome for the events was resolving  Information about lot/batch number was provided. Additional information has been requested.  Follow-up attempts are completed. No further information is expected.
4 year old female - onset of dizziness with seeing dark dots approx. 15 min after given vaccines
Starved; Loss of her voice; Malaise; Epigastric stomach pain; Lost of appetite; Shortness of breath; bad brain fog that comes and goes; lightheaded; headache; fatigue; chills; Weakness; Loss of taste; Indigestion; A spontaneous report was received from a other health professional concerning a 75-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced, sick as heck with many problems/vaccination complication, being starved due to dietary restriction/medical diet, fatigue, malaise, weakness/asthenia, bad brain fog that comes and goes/feeling abnormal, chills but no fever/chills, loss of taste/ageusia, shortness of breath/dyspnea, lightheaded/dizziness, exhaustion/malaise, major indigestion/dyspepsia, stomach weakness and occasional epigastric stomach pain/abdominal pain upper, loss of appetite/decreased appetite, major loss of her voice/aphonia, headache, heart issues/cardiac disorder and feeling poorly/malaise.  The patient's medical history as provided by the reporter included kidney problems, allergies. On FEB 2019, the patient fell extremely ill for three months having high fever, cough and green phlegm which got recovered in MAY 2019, from then the patient has a history of chills and voice issues. The patient got shingles vaccine on 28 DEC 2020. Concomitant medications included vitamins nos, synthroid, allegra, vlt c, colecalciferol and calcium citrate.  On 12 FEB 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 016M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On an unspecified date in FEB 2021, after the mRNA-1273 vaccine injection, the patient experienced the events of fatigue, malaise, weakness, bad brain fog that comes and goes, chills but no fever, loss of taste, shortness of breath, unpredictable dizziness , lightheaded , exhaustion, four days of major indigestion, stomach weakness and occasional epigastric stomach pain, loss of appetite, dietary control, major loss of her voice, headache, heart issues and feeling poorly. The patient was on a strict diet because of her kidney problems and allergies (many allergies). The patient had heart issues that have not been able to be detected by the cardiologists she has seen. No treatment detail was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The event s, fatigue, malaise, weakness, bad brain fog that comes and goes, chills but no fever, loss of taste, shortness of breath, lightheaded , exhaustion, four days of major indigestion stomach weakness, occasional epigastric stomach pain, loss of appetite, dietary control, major loss of her voice, headache, and feeling poorly were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  The patient's medical history of kidney problems, strict diet because of kidney problems, previous illness of 3 months causing voice issues and chills, remain as contributing factors.
This case was reported by a healthcare professional can described the occurrence of flushing in a 4 month old male subject who was vaccainted with Pediarix, Hib vaccine (unspecified manufacturer) and Pneumococcal vaccine (unspecified Manufacturer) for prophylaxis. The subject had no pre existing medical conditions. There were no concurrent medications. On 16 August 2006, the subject received the 1st dose of Pediarix  without any side effects. On 31 October 2006 the subject received 2nd dose of Pediarix in the left thigh plus separate injections of Hib vaccine and Pneumococcal vaccine. The sites of administration of Hib vaccine and pneumococcal vaccine were not provided. On 31 October 2006, less than one day after vaccination with Hib vaccine, Pediarix and Pneumcococal vaccine, the subject experienced flushing, blotchy red rash, lethargy, purple toes and fingers and swollen eyes, ears, feet, and hands. The healthcare professional considered the events were life threatening and clinically significant (or requiring intervention) (OMIC). The subject was seen in the emergency room and was treated with Benadryl and Corticosteroids. The subject was subsequently seen by an allergist. The vaccination course with Pediarix was discontinued. At the time of initial reporting, 02 January 2007, the events were resolved. The healthcare professional considered the events were possibly related to vaccination with Pediarix, Hib vaccine and Pneumococcal vaccine.
Severe nausea, shaking, dizziness, nerve pain and arm soreness that lasted several days.
injection site red; injection site itchy; chills; felt very tired; injection site very sore; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 29-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), FATIGUE (felt very tired), VACCINATION SITE PAIN (injection site very sore), VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE PRURITUS (injection site itchy) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced CHILLS (chills), FATIGUE (felt very tired) and VACCINATION SITE PAIN (injection site very sore). On 29-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE PRURITUS (injection site itchy). On 25-Mar-2021, CHILLS (chills), FATIGUE (felt very tired) and VACCINATION SITE PAIN (injection site very sore) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE PRURITUS (injection site itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Moderna COVID-19 Vaccine EUA Itchy red rash on upper left arm appearing around 4:45 p.m. lasting about 1 - 2 days.
For 4 hours : Rapid resting heart rate (120-130bpm when normal is 70-75bpm)  for 4 hours. Lethargy. Shortness of breath & lightheadedness to the point where I thought I'd faint. Headache.    After 2-3 hours Took 1 advil, waited an hour, then 1 tylenol  & rested. Recovered after light rest.
Fever; Chills; Vomiting; Pounding headache; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pyrexia (received 1st dose on unknown date, refer case US2023AMR130599).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: Fever), chills (Verbatim: Chills), vomiting (Verbatim: Vomiting) and pounding in head (Verbatim: Pounding headache).  Rechallenge with Shingles vaccine was positive. The outcome of the fever, chills, vomiting and pounding in head were resolved (duration 2 days).   It was unknown if the reporter considered the fever, chills, vomiting and pounding in head to be related to Shingles vaccine.   It was unknown if the company considered the fever, chills, vomiting and pounding in head to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR130599   Additional Information: GSK Receipt Date: 18-SEP-2023 The case was received from the patient via interactive digital media. The patient stated he/she was vaccinated with shngles vaccine and was scared of shingles. The patient also stated vaccine was no picnic either, but at least was for only two days not months. The patient experienced fever, chills, vomiting and pounding headaches with both doses. This case is linked with US2023AMR130599, first dose. The follow-up would not required per process.; Sender's Comments:  US-GSK-US2023AMR130599:For first dose
Starting at 02:00 I felt my arm itching. Applied hydrocortisone anti itch to site and felt relief. At 05:45 I got off work and looked at my arm and noticed 3 welts at injection site that are  red, hot, and itchy. I took 50mg of Benadryl and applied witch hazel and am feeling slight relief .
Systemic: Diarrhea-Medium, Systemic: Exhaustion/Lethargy-Medium. Additional Details: Patient  recieved the Pfizer COVID-19 vaccine-2nd dose on 3/21/2022. Later that day, she started feeling fatigue and diarrhea. Adverse reactions are still going on 3/28/2022. Seemed like longer than usual for side effects from a vaccine.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose03/18/21 2nd dose Diagnosed covid positive:09/11/21 Symptom onset:09/08/21 Exposure: Symptoms:
Full body pruritic rash, treating with benadryl and sending pt to allergist for testing
No Adverse event; total of 47 patients that received the vaccines after the use-by date.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (total of 47 patients that received the vaccines after the use-by date.) and NO ADVERSE EVENT (No Adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (total of 47 patients that received the vaccines after the use-by date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (total of 47 patients that received the vaccines after the use-by date.) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (total of 47 patients that received the vaccines after the use-by date.).    Patient was over 18 years of age. No relevant concomitant medications were reported. Staff gave patients vaccines past the use date of 18 Jun 2023. On 23 Jun 2023, 3 doses were administered at administration site 1. No treatment medication reported.   This case was for the 30th patient out of 47 reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-732752 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Vaccination details were added and narrative was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732752:Master case (Patient 1)
Raised red rash on abdomen, right upper arm and neck. Very itchy, treated at home with triamcinolone cream 2-3 times a day for 1 week then resolved.
INCREASED SHORTNESS OF BREATH - INCREASED NEBULIZER TREATMENTS HIVES ON BACK AND FRONT (CHEST) DIZZINESS SEVERE HEADACHE TYLNOL NOT EFFECTIVE I HAVE HAD ADVERSE ACTIONS ON THE LAST ONE AND WAS RELUCTANT TO HAVE THIS ONE DUE TO THIS.
On April 4th, I woke up in the morning with a severe headache, nauseated, and chilly. Those symptoms lasted about 8-10 hours. I was having horrible neck and back pain that I couldn?t lift my head or neck the pain went down right shoulder into arm, hand, and fingers (pointer, ring, middle - tips of fingers were numb). Three days after that I started experiencing tongue, mouth, and lips numbness. They were numb and then the numbness just faded away. By Thursday of that week the NP in my office where I work ordered me a round of steroids and muscles relaxers, but it did nothing. I went and saw my PCP  around mid-April for right arm and shoulder aching and he ordered an X-ray and Physical Therapy. He ordered the x-ray to rule out presumed pinched nerve. I am currently doing the Physical Therapy. I still experience pain it?s getting better but still not 100%.
fainted w/some shaking pale and nauseous for a few minutes after  EMS was called but they chose not to go to ER
Elevated liver functions; This spontaneous case was reported by a physician and describes the occurrence of LIVER FUNCTION TEST INCREASED (Elevated liver functions) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026D21A, 012L20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIVER FUNCTION TEST INCREASED (Elevated liver functions). At the time of the report, LIVER FUNCTION TEST INCREASED (Elevated liver functions) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, Liver function test: normal (normal) normal. On 22-Nov-2021, Liver function test: elevated (High) Elevated liver functions.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided.